SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (11107)7/10/1998 5:33:00 PM
From: AlienTech  Read Replies (1) of 23519
 
>>If Leland truly said that Alibra is 26% more effective he blundered unless there is new data I have not seen.<<

Hey I caint do math ya know. Flunked outa heigh schol.
But have you thought of a carrier in marketting?
someone with your talents can make big bucks.. I mean 6-7 figures here (in francs).. A lot more than you will ever make investing in Leyland..

>>Independent evidence suggests that ALIBRA is almost 50% more effective than MUSE<<

This is pure hype.. VVUS does not belive in hype.. They have worse problems to worry about like what color grass to use at their shiny new factory..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News